The results of other studies that in part were similar to our own, also demonstrated a decreased ATSLC2A4 expression in animal models of type 2 diabetes [34] and in insulin-resistant humans [33], which may serve to support our findings. The gene discussed is INS; the disease is type 2 diabetes mellitus.